Please Wait
Applying Filters...
menu
    • menu
    Evonik

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Fevipiprant

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 872365-14-5, Nvp-qaw039, Qaw039, Fevipiprant [inn], 2pex5n7dq4, Fevipiprant(nvp-qaw039)
    Molecular Formula
    C19H17F3N2O4S
    Molecular Weight
    426.4  g/mol
    InChI Key
    GFPPXZDRVCSVNR-UHFFFAOYSA-N
    FDA UNII
    2PEX5N7DQ4
    Fevipiprant has been used in trials studying the treatment of Asthma, Atopic Dermatitis, and Allergic Rhinitis.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic acid
    2.1.2 InChI
    InChI=1S/C19H17F3N2O4S/c1-11-15(9-17(25)26)14-4-3-7-23-18(14)24(11)10-12-5-6-13(29(2,27)28)8-16(12)19(20,21)22/h3-8H,9-10H2,1-2H3,(H,25,26)
    2.1.3 InChI Key
    GFPPXZDRVCSVNR-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC1=C(C2=C(N1CC3=C(C=C(C=C3)S(=O)(=O)C)C(F)(F)F)N=CC=C2)CC(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    2PEX5N7DQ4
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 1-(4-methanesulfonylbenzyl)-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid

    2. Nvp-qaw039

    2.3.2 Depositor-Supplied Synonyms

    1. 872365-14-5

    2. Nvp-qaw039

    3. Qaw039

    4. Fevipiprant [inn]

    5. 2pex5n7dq4

    6. Fevipiprant(nvp-qaw039)

    7. Qaw-039

    8. 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic Acid

    9. (1-(4-((methane)sulfonyl)-2-trifluoromethylbenzyl)-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid

    10. 2-(1-((4-methanesulfonyl-2-(trifluoromethyl)phenyl)methyl(-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid

    11. 2-(2-methyl-1-(4-(methylsulfonyl)-2-(trifluoromethyl)benzyl)-1h-pyrrolo[2,3-b]pyridin-3-yl)acetic Acid

    12. 2-methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-1h-pyrrolo[2,3-b]pyridine-3-acetic Acid

    13. Fevipiprant [usan:inn]

    14. Unii-2pex5n7dq4

    15. Qaw 039

    16. Fevipiprant [jan]

    17. Fevipiprant [usan]

    18. Fevipiprant [who-dd]

    19. Fevipiprant (jan/usan/inn)

    20. Gtpl8995

    21. Schembl1940595

    22. Chembl3137332

    23. Dtxsid501336031

    24. Hms3743e19

    25. Bcp25015

    26. Ex-a2495

    27. Bdbm50233520

    28. Mfcd22548206

    29. Zinc43101772

    30. Ab85348

    31. Cs-5956

    32. Db12011

    33. Fevipiprant; Nvp-qaw039; Qaw039

    34. Sb16897

    35. Ac-31956

    36. As-74870

    37. Hy-16768

    38. Ds-022511

    39. Ft-0774596

    40. D10631

    41. Q27077292

    42. 1-(4-methanesulfonylbenzyl)-2-methyl-1h-pyrrolo(2,3-b)pyridin-3-yl)acetic Acid

    43. (2-methyl-1-{[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl}-1h-pyrrolo[2,3-b]pyridin-3-yl)acetic Acid

    44. [1-(4-methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl]-acetic Acid

    45. [2-methyl-1-[4-(methylsulfonyl)-2-(trifluoromethyl)benzyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]acetic Acid

    46. 2-(1-{[4-methanesulfonyl-2-(trifluoromethyl)phenyl]methyl}-2-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl)acetic Acid

    47. 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[5,4-b]pyridin-3-yl]acetic Acid

    48. Fsy

    2.4 Create Date
    2007-12-10
    3 Chemical and Physical Properties
    Molecular Weight 426.4 g/mol
    Molecular Formula C19H17F3N2O4S
    XLogP32.8
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count8
    Rotatable Bond Count5
    Exact Mass426.08611269 g/mol
    Monoisotopic Mass426.08611269 g/mol
    Topological Polar Surface Area97.6 Ų
    Heavy Atom Count29
    Formal Charge0
    Complexity709
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of asthma